Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA

Links shared publicly online about this topic.

  • 801
    total visits

Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA

medicalnewstoday.com

Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxificati

View full resource at medicalnewstoday.com

Tags: Addiction, Substance Addiction, Drug, FDA, Psychology

  • Share

Most Recently Shared on October 15, 2010 at 1:05 am By:

mnt_psychology MNT Psychology News

Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA http://mnt.to/3LfM #psychology

2 years ago...

Also Shared By:

medical_tweets medical_tweets

MNT Health News MNT Health News

MNT Alcohol / Addict MNT Alcohol / Addict

Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The Lancet

medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been pView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 12:05 pm By:

mnt_alcoholadd MNT Alcohol / Addict Health News

Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The ... http://mnt.to/3V8G

1 year ago...

Alkermes Announces FDA Approval Of VIVITROL For Prevention Of Relapse To Opioid Dependence - QualityPoint Technologies

qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL (naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification. VIVITROL is now the first and only non-narcotic, non-addictive, once-monthly medication approved for the treatment of opioid dependence. VIVITROL was approved by the FDA in 2006 for the treatment of alcohol dependence and should be used as part of View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 16, 2010 at 10:49 pm By:

MedicalFeed MedicalFeed Health News Feed

Alkermes Announces FDA Approval Of VIVITROL® For Prevention Of Relapse To Opioid Dependence: Alkermes, Inc. (NASD... http://bit.ly/bCwk5v

2 years ago...

Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA - QualityPoint Technologies

qualitypointtech.net — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxification therapy. The injection is administered into the muscle (intramuscularly) once per month. Naltrexone is an opioid receptor antagonist - it blocks the brain's opioid receptors. Examples of opioids include heroin, morphine, codeine, and thebaine...View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 15, 2010 at 9:49 am By:

MedicalFeed MedicalFeed Health News Feed

Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA: Vivitrol (Naltrexone) in injection... http://bit.ly/aspHvY

2 years ago...

FDA Approves Vivitrol to Treat Opioid-dependent Patients

drugs.com — “Vivitrol (naltrexone) is used to treat alcohol dependence and opioid dependence. Includes Vivitrol side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 13, 2010 at 11:08 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves Vivitrol to Treat Opioid-dependent Patients: ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Dr... http://bit.ly/98nTjo #drug

2 years ago...

FDA Approves Injectable Drug To Treat Opioid-Dependent Patients

medicalnewstoday.com — “The U.S. Food and Drug Administration approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.Vivitrol is an extended-View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 13, 2010 at 4:21 pm By:

mnt_alcoholadd MNT Alcohol / Addict Health News

FDA Approves Injectable Drug To Treat Opioid-Dependent Patients http://mnt.to/3L8Z #alcohol #addiction

2 years ago...

Vivitrol approved for opioid dependence - MPR

empr.com — “The FDA has approved Vivitrol (naltrexone for injection, from Alkermes) to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 13, 2010 at 3:43 pm By:

eMPR MPR Medical Publisher

MPR News: Vivitrol approved for opioid dependence: The FDA has approved Vivitrol (naltrexone extended-release inje... http://bit.ly/9cWdEE

2 years ago...

Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence - QualityPoint Technologies

qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on September 19, 2010 at 2:01 pm By:

MedicalFeed MedicalFeed Health News Feed

Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence: Alkermes, Inc.... http://bit.ly/aQwbNM

2 years ago...

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence

news-medical.net — “Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 17, 2010 at 4:54 am By:

NewsMedical News-Medical.Net Health News

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence: Alkermes, Inc. today annou... http://bit.ly/aga8bQ

2 years ago...

Alkermes to Seek FDA Approval of Anti-Addiction Drug | Xconomy

xconomy.com — “Cambridge,MA-based biotech Alkermes said this morning that its long-acting naltrexone injection (Vivitrol) was more effective in treating opioid drug dependenceView full resource at xconomy.com

  • View Related
  • Share

Most Recently Shared on November 17, 2009 at 12:53 pm By:

FierceBiotech FierceBiotech Health News

RT @CenterWatch: Alkermes to file for approval of Vivitrol for opioid addiction in the first half of 2010. http://ow.ly/CRAQ

3 years ago...

Advertisement